Kawasaki disease
Mucocutaneous lymph node syndrome; Infantile polyarteritis
Kawasaki disease is a rare condition that involves inflammation of the blood vessels. It occurs in children.
Causes
Kawasaki disease occurs most often in Japan, where it was first discovered. The disease is seen more often in boys than in girls. Most of the children who develop this condition are younger than age 5.
Kawasaki disease is not well understood and the cause is yet unknown. It may be an autoimmune disorder . The problem affects the mucous membranes, lymph nodes, walls of the blood vessels, and the heart.
Autoimmune disorder
An autoimmune disorder occurs when the body's immune system attacks and destroys healthy body tissue by mistake. There are more than 80 types of aut...
Symptoms
Kawasaki disease often begins with a fever of 102°F (38.9°C) or higher that does not go away. The fever is often as high as 104°F (40°C). A fever lasting at least 5 days is a common sign of the disorder. The fever may last for up to 2 weeks. The fever often does not come down with normal doses of acetaminophen (Tylenol) or ibuprofen.
Fever
Fever is the temporary increase in the body's temperature in response to a disease or illness. A child has a fever when the temperature is at or abov...
Other symptoms often include:
- Bloodshot or red eyes (without pus or drainage)
- Bright red, chapped, or cracked lips
- Red mucous membranes in the mouth
- Strawberry tongue, white coating on the tongue, or visible red bumps on the back of the tongue
- Red palms of the hands and the soles of the feet
- Swollen hands and feet
- Skin rashes on the middle of the body, NOT blister-like
- Peeling skin in the genital area, hands, and feet (mostly around the nails, palms, and soles)
- Swollen lymph nodes in the neck (often only one lymph node is swollen)
- Joint pain and swelling, often on both sides of the body
Additional symptoms may include:
- Irritability
- Diarrhea, vomiting, and abdominal pain
- Cough and runny nose
Exams and Tests
Tests alone cannot diagnose Kawasaki disease. Most of the time, the health care provider will diagnose the disease when a child has most of the common symptoms.
In some cases, a child may have a fever that lasts more than 5 days, but not all the common symptoms of the disease. These children may be diagnosed with atypical Kawasaki disease.
All children with fever lasting more than 5 days should be checked for Kawasaki disease by a provider. Children with the disease need early treatment for a good outcome.
The following tests may be done:
- Chest x-ray
-
Complete blood count
Complete blood count
A complete blood count (CBC) test measures the following:The number of red blood cells (RBC count)The number of white blood cells (WBC count)The tota...
-
C-reactive protein
(CRP)
C-reactive protein
C-reactive protein (CRP) is produced by the liver. The level of CRP rises when there is inflammation throughout the body. It is one of a group of p...
-
Erythrocyte sedimentation rate (ESR
)
Erythrocyte sedimentation rate (ESR
ESR stands for erythrocyte sedimentation rate. It is commonly called a "sed rate. "It is a test that indirectly measures how much inflammation is in...
- Ferritin
-
Serum albumin
Serum albumin
Albumin is a protein made by the liver. A serum albumin test measures the amount of this protein in the clear liquid portion of the blood. Albumin c...
- Serum transaminase
-
Urinalysis
- may show pus in the urine or
protein in the urine
Urinalysis
Urinalysis is the physical, chemical, and microscopic examination of urine. It involves a number of tests to detect and measure various compounds th...
Protein in the urine
The protein urine dipstick test measures the presence of proteins, such as albumin, in a urine sample. Albumin and protein can also be measured using...
-
Echocardiogram
Echocardiogram
An echocardiogram is a test that uses sound waves to create pictures of the heart. The picture and information it produces is more detailed than a s...
-
Electrocardiogram
Electrocardiogram
An electrocardiogram (ECG) is a test that records the electrical activity of the heart.
Tests such as ECG and echocardiography are done to look for signs of myocarditis , pericarditis , arthritis , aseptic meningitis, and inflammation of the coronary arteries.
Myocarditis
Myocarditis is inflammation of the heart muscle. The condition is called pediatric myocarditis when it occurs in children.
Pericarditis
Pericarditis is a condition in which the sac-like covering around the heart (pericardium) becomes inflamed.
Arthritis
Arthritis is inflammation of one or more joints. A joint is the area where 2 bones meet. There are more than 100 different types of arthritis....
Treatment
Children with Kawasaki disease need hospital treatment. Treatment must be started right away to prevent damage to the coronary arteries and heart.
Intravenous gamma globulin is the standard treatment. It is given in high doses. The child's condition often gets much better within 24 hours of treatment with IV gamma globulin.
High-dose aspirin is often given along with IV gamma globulin.
Even with standard treatment, up to 1 in 4 children may still develop problems in their coronary arteries. Some research suggests that adding steroids or tumor necrosis factor (TNF) inhibitors such as Enbrel to the treatment routine may help. However, there still needs to be better tests to tell which children will benefit from added forms of treatment.
Outlook (Prognosis)
Most children can recover fully when the disease is caught and treated early. About 1 in 100 children die from heart problems caused by the disease. People who have had Kawasaki disease should have an echocardiogram every 1 to 2 years to screen for heart problems.
Possible Complications
Kawasaki disease can cause inflammation of blood vessels in the arteries, especially the coronary arteries. This can lead to aneurysm. Rarely, it can lead to a heart attack at a young age or later in life.
When to Contact a Medical Professional
Call your provider if symptoms of Kawasaki disease develop. Swelling and redness develop in the affected areas such as the palms and soles of the feet. This, along with an ongoing high fever that does not come down with acetaminophen or ibuprofen, should be checked by a provider.
Prevention
There are no known ways to prevent this disorder.
References
Dominguez SR, Anderson MS. Advances in the treatment of Kawasaki disease. Curr Opin Pediatr . 2013;25(1):103-109. PMID: 23283289 www.ncbi.nlm.nih.gov/pubmed/23283289 .
Mason JC. Rheumatic diseases of the cardiovascular system. In: Mann DL, Zipes DP, Libby P, Bonow RO, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine . 10th ed. Philadelphia, PA: Elsevier Saunders; 2014:chap 84.
-
Kawasaki's disease - edema of the hand - illustration
Kawasaki's disease can produce various rashes and skin manifestations. This photograph shows mild swelling (edema) and redness associated with the disease. The hands and feet may be tender to touch and the skin may peel once the redness begins to fade.
Kawasaki's disease - edema of the hand
illustration
-
Kawasaki's disease, peeling of the fingertips - illustration
Kawasaki's disease causes various rashes and manifestations of the mucous membranes and skin. This photograph shows the skin peeling away from the fingertips. This can also occur on the palms, toes, soles, and around the nails.
Kawasaki's disease, peeling of the fingertips
illustration
-
Kawasaki's disease - edema of the hand - illustration
Kawasaki's disease can produce various rashes and skin manifestations. This photograph shows mild swelling (edema) and redness associated with the disease. The hands and feet may be tender to touch and the skin may peel once the redness begins to fade.
Kawasaki's disease - edema of the hand
illustration
-
Kawasaki's disease, peeling of the fingertips - illustration
Kawasaki's disease causes various rashes and manifestations of the mucous membranes and skin. This photograph shows the skin peeling away from the fingertips. This can also occur on the palms, toes, soles, and around the nails.
Kawasaki's disease, peeling of the fingertips
illustration
Review Date: 4/28/2015
Reviewed By: Gordon A. Starkebaum, MD, Professor of Medicine, Division of Rheumatology, University of Washington School of Medicine, Seattle, WA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.